Description

Treviamet is a combination of two active ingredients: Sitagliptin and Metformin. It is used to improve glycemic control in patients with type 2 diabetes mellitus. Treviamet can be used as monotherapy or in combination with other antidiabetic medications, such as sulfonylureas or thiazolidinediones